Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

When less is more: The association between the expression of polymorphic CYPs and AFB1-induced HCC.

European journal of clinical investigation - 1 Dec 2024

Mohamed Asmaa Ashraf, Armanious Monica, Bedair Rana W, Amin Nada Sherif, El Tayebi Hend M

Abstract excerpt

BACKGROUND: An individual's genetic fingerprint is emerging as a pivotal predictor of numerous disease- and treatment-related factors. Single nucleotide polymorphisms (SNPs) in drug-metabolizing enzymes play key roles in an individual's exposure to a malignancy-associated risk, such as Aflatoxin B1 (AFB1)-induced hepatocellular carcinoma (HCC). AIM: This study aimed at reviewing literature on the polymorphisms...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aflatoxin B1
Share to Carcinoma, Hepatocellular

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Cytochrome P-450 Enzyme System

Share to Genetic Predisposition to Disease

Share to Liver Neoplasms

Share to Polymorphism, Single Nucleotide

Source

Identifiers

PMID: 39099542
DOI: 10.1111/eci.14297

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

When less is more: The association between the expression of polymorphic CYPs and AFB1-induced HCC.PMID 39099542Read ↗

Genetic polymorphism of metabolic enzymes P450 (CYP) as a susceptibility factor for drug response, toxicity, and cancer risk.Semantic proximity Read ↗

Polymorphic Variants of Cytochrome P450: Relevance to Cancer and Other Diseases.Semantic proximity Read ↗

AKR7A3 rs1738023 Association with Susceptibility to Female Hepatocellular Carcinoma and Its Role in AFB1 Metabolism and TumorSemantic proximity Read ↗

Cytochrome P450: Polymorphisms and Roles in Cancer, Diabetes and AtherosclerosisSemantic proximity Read ↗

Polymorphism of CYP450 and cancer susceptibility.Semantic proximity Read ↗

Genetic Features of Aflatoxin-Associated Hepatocellular Carcinoma.Semantic proximity Read ↗

Cytochrome P450 gene polymorphism and cancer.Semantic proximity Read ↗

Association of CYP1A2 genetic polymorphisms with hepatocellular carcinoma susceptibility: a case-control study in a high-risk region of China.Semantic proximity Read ↗

Molecular genetics and epigenetics of the cytochrome P450 gene family and its relevance for cancer risk and treatment.Semantic proximity Read ↗

Cytochrome P450 in Cancer Susceptibility and Treatment.Semantic proximity Read ↗

Genic-intergenic polymorphisms of CYP1A genes and their clinical impact.Semantic proximity Read ↗

The rs3957357C>T SNP in GSTA1 Is Associated with a Higher Risk of Occurrence of Hepatocellular Carcinoma in European Individuals.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.